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Leading Edge
MinireviewPattern Recognition in Innate Immunity
Our immune system is continuously faced with the 
challenge of protecting us from infection against an 
army of pathogens. When infection does occur, the 
effective elimination of most pathogens requires the 
activation of both the innate and the adaptive tiers 
of the immune system. The innate immune response 
in large part relies on phagocytic and granulocytic 
cells expressing germline-encoded invariant recep-
tors that recognize pathogen-associated molecular 
patterns (Medzhitov and Janeway, 2002). These pat-
tern-recognition receptors mediate killing of the rec-
ognized microbe by triggering phagocytosis. Apart 
from the prototypic Toll-like receptors, there has been 
an increasing appreciation of the importance of other 
kinds of pattern-recognition receptors (reviewed in 
Brown [2006]). Soluble pattern-recognition recep-
tors, such as mannan binding lectin, can contribute 
to pathogen clearance via activation of the comple-
ment system. The complement system is a class of 
over 20 soluble and cell-surface proteins that react 
to the exposure to foreign antigens by initiating a 
regulated cascade of reactions. There are three major 
pathways of complement activation (Figure 1). Bind-
ing of mannan binding lectin to microbial surface acti-
vates the complement lectin pathway that converges 
with the classical pathway at the level of comple-
ment C4 (a component of one of the heteromultimeric 
enzyme complexes). Even though the complement 
system evolutionarily predates the adaptive immune 
response, it has been adapted to mediate crosstalk 
between the adaptive and innate responses. Of the 
three pathways, the classical pathway of complement 
activation—which is initiated by immunoglobulins and 
then proceeds via C1q (a subunit of the C1 enzyme 
complex)—is thought to participate most directly in 
the adaptive response. The alternative pathway of 
complement is considered the original complement 
pathway and is even found in ascid-
ians, such as sea squirts and sea 
urchins (reviewed in Fujita [2002]). 
Although the three pathways are acti-
vated independently, it is becoming 
increasingly apparent that they inter-
act at various levels.
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Protection from acute infection requires an immediate response by the host innate immune 
system. Two recent Cell papers, including one in this issue, provide new insight into the role 
of the complement system in response to blood-borne pathogens.
Figure 1. The Three Complement  
Pathways
Downstream complement activation has the 
potential for direct destruction of pathogens 
via the C5–C9 membrane attack complex 
(MAC). The C3a and C5a fragments function 
as chemokines, recruiting phagocytic and 
granulocytic cells to sites of inflammation. 
SIGN-R1 can activate the classical pathway of 
complement (Kang et al., 2006). CRIg is a new 
clearance receptor recognizing the C3b and 
iC3b fragments of complement C3 (Helmy et 
al., 2006; MBL, mannan binding lectin; MASP, 
MBL-associated serine protease).Cell 125, April 7, 2006 ©2006 Elsevier Inc. 29
In this minireview, we focus on the role of comple-
ment in opsonization, the process by which prod-
ucts of the complement pathway coat antigens. For 
example, fragments of complement C3 and C4 bind 
covalently to a pathogen’s surface and in effect tag 
the pathogen as foreign. Complement receptors rec-
ognizing these tags modulate the subsequent immune 
response or directly target the pathogen for clearance. 
In a recent issue of Cell, Helmy et al. (2006) described 
a new complement receptor of the Ig superfamily, 
CRIg, which mediates the complement-dependent 
clearance of pathogens by Kupffer cells in the liver. In 
this issue of Cell, Kang et al. (2006) introduce a new 
mechanism of classical pathway activation by pneu-
mococcal capsular polysaccharides. They make the 
surprising observation that the C-type lectin pattern-
recognition receptor SIGN-1 binds complement C1q, 
leading to activation of the classical pathway. Here, 
we describe the new insights generated by their find-
ings and integrate them into a more general pattern 
of complement-mediated recognition and clearance 
of pathogens. We will also discuss the implications of 
these studies on the regulation of local infection and 
systemic autoimmune disease.
New Pattern-Recognition Receptors in Comple-
ment Activation and Complement-Mediated 
Clearance
CRIg: Immune Clearance Revisited
Four receptors for fragments of complement C3 had 
been described to date (reviewed by Holers et al. 
[1992]). To this panel Helmy et al. (2006) now add a 
fifth member, CRIg. They demonstrate that CRIg has 
affinity for C3b and iC3b, but not for other comple-
ment components. CRIg is expressed on tissue-resi-
dent macrophages, including Kupffer cells in the liver. 
In the absence of CRIg, C3-opsonized particles fail 
to bind to Kupffer cells, indicating that CRIg is the 
dominant C3 receptor on Kupffer cells, in spite of the 
fact that they may also express the receptor CR3 (also 
called Mac-1, CD11b/CD18). Importantly, Helmy et al. 
(2006) identify CRIg as a phagocytic receptor for the 
C3-dependent clearance of blood-borne pathogens. 
The absence of CRIg strongly enhances susceptibility 
to these pathogens.
Rapid capture of bacteria in the liver during the first 
minutes to hours after introduction to the blood is 
crucial to prevent systemic bacteremia. Clearance of 
bacteria through the liver involves both adaptive (i.e., 
FcR-mediated phagocytosis) and innate mechanisms. 
Innate immunity-mediated mechanisms include both 
scavenger and complement receptors. For instance, 
CR3 on Kupffer cells is implicated in preventing bac-
teremia. It now appears that a second receptor, CRIg, 
mediates clearance of C3-opsonized pathogens.
In addition to clearance of pathogens, CRIg+ Kupffer 
cells could play an important role in removing comple-
ment-tagged self-antigens, such as apoptotic cells 30 Cell 125, April 7, 2006 ©2006 Elsevier Inc.and cell remnants. In the prototypical autoimmune dis-
ease systemic lupus erythematosous, the deposition 
of immune complexes of self-antigen and self-reac-
tive antibody in the kidney leads to glomerulonephri-
tis. Defects in complement are thought to exacerbate 
Lupus via a reduction in normal immune complex 
clearance, resulting in an increased deposition of 
pathogenic complexes in the kidneys, enhancing 
inflammation and ultimately resulting in kidney failure. 
Given the importance of CRIg in clearance, it could 
play an important role in limiting renal injury through 
rapid clearance of potentially pathogenic immune 
complexes. It will be therefore be very informative to 
learn whether CRIg-deficient mice are predisposed to 
the development of autoimmune disease.
SIGN-R1: Lectin Activation of the Classical 
Complement Pathway
SIGN-R1 is a cell surface C-type lectin receptor with 
homology to DC-SIGN. Earlier work on this receptor 
has shown that it is expressed on marginal-zone mac-
rophages (Geijtenbeek et al., 2002) and is important in 
resistance to pneumococcal infection (Lanoue et al., 
2004). Other studies found that immunity to Strepto-
coccus pneumoniae also requires the classical path-
way of complement (Brown et al., 2002). Kang et al. 
(2006) now elegantly integrate these findings into a 
single concept by showing that SIGN-R1 activates 
the classical pathway of complement on the surface 
of marginal-zone macrophages. SIGN-R1 binds C1q 
as well as S. pneumoniae polysaccharide, leading to 
the C4-dependent deposition of C3 on the captured 
polysaccharide and on S. pneumoniae. Remarkably, 
C3 deposition does not require the involvement of 
antibodies, making it a classical but immunoglobulin-
independent pathway of complement activation. This 
is the first description of a cell surface lectin directly 
initiating the classical pathway of complement activa-
tion. Given that the absence of C3 results in a greater 
susceptibility to S. pneumoniae than deficiency in 
SIGN-R1, it is likely that natural IgM-activated clas-
sical pathway and conceivably other lectins also con-
tribute to S. pneumoniae resistance.
Macrophages express a range of lectins, for many 
of which the ligands remain unknown. The emerging 
role of SIGN-R1 as a complement activator, as well as 
the identification of CRIg as a new clearance recep-
tor on Kupffer cells could provide insight into additional 
mechanisms of the innate response against blood-
borne pathogens.
Convergence on Complement Effector 
 Mechanisms in the Spleen
The spleen is the main and final line of defense against 
blood-borne pathogens. Splenic structure is uniquely 
suited to mediate the extremely rapid response that is 
required when sepsis occurs (reviewed in Mebius and 
Kraal [2005]). Most of the blood passes through the mar-
ginal zone, bringing the contents into intimate contact 
with marginal-zone macrophages, marginal-zone B cells, 
and a subset of dendritic cells (Figure 2). Marginal-zone 
macrophages are defined by their expression of SIGN-R1 
and the scavenger receptor MARCO. SIGN-R1 mediates 
complement activation upon exposure to certain micro-
bial polysaccharides (Kang et al., 2006). The marginal 
zone is also rich in a subset of B-lymphocytes termed 
marginal-zone B cells. They are characterized by distinct 
cell-surface protein expression patterns that include 
high expression of complement receptors. Another sub-
set of macrophages, marginal-zone metallophilic mac-
rophages, line the inner edge of the marginal sinus and 
are defined by expression of Sialoadhesin (also called 
Siglec-1; sialic acid binding Ig-like lectin). Deficiencies in 
Siglec-1, as well as in the scavenger receptors MARCO 
and SR-A, were shown to disrupt marginal-zone compo-
sition and function (Oetke et al., 2006; Chen et al., 2006). 
Both MARCO- and SIGN-R1-deficient mice are known to 
be more susceptible to S. pneumoniae when compared 
to wild-type mice (Arredouani et al., 2004, Lanoue et al., 
2004) but still notably less sensitive than C3-deficient 
mice. It appears that overlapping pathogen-recognition 
pathways converge at the level of C3. Therefore, comple-
ment may be the dominant clearance mechanism within 
the spleen. This may become increasingly relevant when 
infection is more complicated, such as infection by more 
than one pathogen (Lysenko et al., 2005). Not all patho-
gens equally activate all innate defense mechanisms, 
and not all defense mechanisms are equally effective 
against all pathogens. Channeling responses from an 
array of broadly specific pattern-recognition receptors 
into a restricted number of effector mechanisms may be 
the best way to ensure reliable immu-
nity against an unpredictable and con-
stantly changing environment.
The blood-borne phase of infections 
is usually preceded by microbial coloni-
zation of peripheral tissues or mucosal 
surfaces. Innate immune mechanisms 
also battle the pathogen on-site. Both 
natural antibodies and pattern-recog-
nition receptors such as mannan bind-
ing lectin activate complement directly 
upon exposure to microbial antigens, 
opsonizing the pathogen for phagocy-
tosis and recruiting granulocytes and 
phagocytes in the process. Bacterial 
antigens are transported to the drain-
ing lymph node, where adaptive immune responses are 
initiated. Even though lymph nodes lack the marginal 
zone that is optimally suited to handle pathogens, most 
infections are contained before they become systemic. In 
the absence of marginal-zone B cells and marginal-zone 
macrophages in the lymph node, antigen must be trans-
ported into follicles via other mechanisms for the prim-
ing of the adaptive immune response to occur (Figure 
2). Subcapsular sinus macrophages and dendritic cells 
are implicated in this process (Martinez-Pomares et al., 
1996, Berney et al., 1999). Local complement produc-
tion in the lymph node is important for antiviral immunity 
(Verschoor et al., 2003), suggesting that mechanisms of 
pathogen recognition and clearance may be common 
between peripheral lymph nodes and spleen. However, 
further details regarding specific pattern-recognition 
receptors and the cell types involved will be necessary 
to complete our understanding of pathogen clearance in 
the lymph node.
Dual Recognition of Foreign and Self-Antigens by 
Pattern-Recognition Receptors
Both macrophages and dendritic cells express the man-
nose receptor, ligands for which are present on a range 
of microbes, as well as on marginal-zone metallophilic 
macrophages and a subset of dendritic cells and include 
Siglec-1. Other members of the Siglec family have 
diverse expression patterns and harbor the potential 
for recognizing both self- and foreign antigens. Pattern 
recognition might therefore have evolved out of a need 
for self-recognition upon increasing cellular diversifica-
tion, being adapted for defense purposes later (Gordon, 
Figure 2. Structure of the Spleen versus 
that of the Lymph Node
Apart from the lack of marginal zones, lymph 
nodes strongly resemble the splenic white pulp. 
In the absence of marginal-zone B cells and 
marginal-zone macrophages, antigen-transport 
processes are likely to differ substantially be-
tween the lymph node and the spleen.Cell 125, April 7, 2006 ©2006 Elsevier Inc. 31
2002). Introduction of pneumococcal polysaccharide or 
model carbohydrate antigens (referred to as T-indepen-
dent type 2 antigens) into the blood leads to rapid local-
ization on marginal-zone macrophages. Marginal-zone 
B cells take over the antigen in a complement-depen-
dent manner (Kang et al., 2006) and transport it into 
the follicles where it is deposited on follicular dendritic 
cells. The absence of marginal-zone B cells or disrup-
tion of marginal-zone macrophages interferes with this 
process (Karlsson et al., 2003), as follicular localization 
of the antigen is abolished, and the subsequent adap-
tive immune response is strongly impaired (Guinamard 
et al., 2000). Thus, the various subsets of macrophages 
and marginal-zone B cells are highly interdependent. 
The new results by Kang et al. (2006) provide further 
insight into this intricate network of marginal-zone mac-
rophages and marginal-zone B cells and the recognition 
of T-independent antigens. It will be important to learn 
whether binding of bacteria by SIGN-R1 enhances inter-
action with C1q and subsequent complement activation. 
Moreover, it is tempting to speculate that signaling via 
SIGN-R1 and complement receptors is responsible for 
release of the antigen-laden marginal-zone B cells into 
the follicles.
Conclusions
The complement system has been studied intensely 
since its identification over a century ago. Helmy et al. 
(2006) and Kang et al. (2006) demonstrate additional 
levels of regulation in complement-mediated pathogen 
recognition and clearance. Their findings have impor-
tant implications for complement activation in peripheral 
immune responses and immune clearance. No doubt 
these new and interesting results will spark continued 
interest in this important area of research.
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